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Pulmonary dissemination of tumor cells after extended resection of
thyroid carcinoma with cardiopulmonary bypass
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Kyoto, Japan
Application of cardiopulmonary bypass (CPB) to onco-logic surgery is still controversial. One of the possibledisadvantages of CPB application to operations formalignancies is hematogenous dissemination of tu-
mor cells.1 However, to our knowledge, no such case has been
reported.2 Here we describe a case of intrapulmonary tumor spread
after surgical resection of intrathoracic extension of thyroid pap-
illary carcinoma with CPB.
Clinical Summary
A 78-year-old Japanese woman was admitted to Kyoto University
Hospital, with severe and uncontrollable pain in the right side of
the neck. A mass extending from the right side of the neck into the
right internal jugular vein, superior vena cava, and right atrium
was revealed by means of computed tomographic scanning, mag-
netic resonance imaging, ultrasonography, and fluorodeoxyglu-
cose–positron emission scanning, but no definite diagnosis was
obtained. No intrapulmonary lesions were noted on preoperative
chest radiography and computed tomographic scanning. Because
of persistent pain and moderate heart failure, the patient underwent
semiemergency surgery. Intrathoracic extension of papillary thy-
roid carcinoma was diagnosed by means of intraoperative frozen
section. En bloc resection of the thyroid tumor, the right subcla-
vian vein, the superior vena cava, and part of the right atrium was
performed by using CPB through a median sternotomy. CPB was
performed with cannulation of the ascending aorta, left innominate
vein, and inferior vena cava. The duration of CPB was 27 minutes,
with transfusion of 640 mL of concentrated red blood corpuscles.
The surgical margins were examined with intraoperative frozen
sections and confirmed to be free of tumor cells.
The patient was extubated on postoperative day (POD) 1 but
required reintubation on POD 3 as a result of airway mucus
retention. Two weeks after the operation, bilateral infiltration with
nodular shadows became evident (Figure 1). Pseudomonas aerugi-
nosa was detected in a bronchoscopy specimen obtained on POD
14. Thyroid carcinoma cells were detected in bronchoalveolar
lavage fluid from the left B3 bronchus on POD 24. The patient died
on POD 36 as a result of respiratory failure. Autopsy was not
performed.
Comments
There are 2 possible mechanisms through which CPB might con-
tribute to hematogenous dissemination of tumor cells.
First, tumor cells contaminated in the reservoir blood might
spread through the arterial cannula. Akchurin et al3 found that in
patients who underwent combined oncologic and cardiovascular
surgery, tumor cells were seen only on the internal (machine)
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Figure 1. Chest computed tomographic scan on POD 13 revealed
bilateral multiple pulmonary nodules (arrows) with bilateral in-
filtration. Thyroid carcinoma cells were detected in bronchoal-
veolar lavage fluid on POD 24.
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surface but not the outer (patient) surface of the filters, and they
concluded that CPB might be used without increasing the risk of
hematogenous tumor dissemination. However, the above mecha-
nism could still conceivably operate in particular situations, such
as a long CPB period, re-use of suctioned blood, and intravascular
extension of the tumor. Because blood transfusion is believed to be
a risk factor in oncologic surgery, surgeons tend to prefer re-use of
suctioned blood rather than transfusion. In the present case intra-
vascular tumor growth was seen in the superior vena cava. Fur-
thermore, suctioned blood from the surgical field was re-used
through the Cell-Saver System (Compact Advanced Wash Set
BT745C/125; Dideco s.p.a., Mirandola, Italy).
Second, modification of homeostasis by CPB may liberate
tumor cells that have already been spread preoperatively but the
growth or migration of which has been suppressed by the host
defense system. Boldt and associates4 reported that circulating
adhesion molecules were increased during cardiac surgery but
remained unchanged in long-duration abdominal or lung opera-
tions.
Although not proven conclusively, it is strongly suspected that
CPB played a significant role in the early postoperative tumor
dissemination seen in the present case, which illustrates a possible
disadvantage of CPB use in oncologic surgery. Our current policy
for application of CPB to cancer surgery is strict patient selection
and no re-use of suctioned blood.
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